Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-057797)

Filing Details

Accession Number:: 0001209191-18-057797
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-08 18:04:13
Reporting Period:: 2018-11-07

Accepted Time:: 2018-11-08 18:04:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1328143	Adamas Pharmaceuticals Inc	ADMS	Pharmaceutical Preparations (2834)	421560076

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1604541	T Gregory Went	C/O Adamas Pharmaceuticals, Inc. 1900 Powell St., Suite 1000 Emeryville CA 94608	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-11-07	3,850	$12.98	199,242	No	4	P	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	182,610	Direct